Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association
暂无分享,去创建一个
Roger S McIntyre | K. Matthews | B. McCrindle | R. McIntyre | M. Carnethon | G. Miller | C. Stoney | B. Goldstein | Brian W McCrindle | Karen A Matthews | Mercedes R Carnethon | G. Raghuveer | Hank Wasiak | Benjamin I Goldstein | Gregory E Miller | Geetha Raghuveer | Catherine M Stoney | Hank Wasiak
[1] R. Lam,et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. , 2009, The international journal of neuropsychopharmacology.
[2] R. Dantzer,et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy , 2001, Psychoneuroendocrinology.
[3] C. Correll. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[4] A. Dunn,et al. Molecular Mechanisms of Actions of Interleukin-6 on the Brain, with Special Reference to Serotonin and the Hypothalamo-Pituitary-Adrenocortical Axis , 1999, Neurochemical Research.
[5] V. Meyer-Rochow,et al. Insulin Resistance and Depressive Symptoms in Young Adult Males: Findings From Finnish Military Conscripts , 2007, Psychosomatic medicine.
[6] R. Post,et al. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. , 2008, Revista brasileira de psiquiatria.
[7] J. Danesh,et al. C‐reactive protein and coronary heart disease: a critical review , 2008, Journal of internal medicine.
[8] B. Grant,et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2005, The Journal of clinical psychiatry.
[9] R. Badenhop,et al. A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.
[10] T. Muto,et al. Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders , 2012, Environmental Health and Preventive Medicine.
[11] N. Frasure-smith,et al. Reflections on Depression as a Cardiac Risk Factor , 2005, Psychosomatic medicine.
[12] Peter Bennett,et al. The metabolic syndrome in children and adolescents – an IDF consensus report , 2007, Pediatric diabetes.
[13] R. Olvera,et al. Medical comorbidity among youth diagnosed with bipolar disorder in the United States. , 2009, The Journal of clinical psychiatry.
[14] G. Miller,et al. Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity , 2008, Brain, Behavior, and Immunity.
[15] M. Garg,et al. Reduced mania and depression in juvenile bipolar disorder associated with long-chain ω-3 polyunsaturated fatty acid supplementation , 2009, European Journal of Clinical Nutrition.
[16] R. S. Smith. The macrophage theory of depression. , 1991, Medical hypotheses.
[17] Andrew H. Miller,et al. Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.
[18] H. Seo,et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.
[19] T. Dinan,et al. Antidepressant therapy and C-reactive protein levels , 2006, British Journal of Psychiatry.
[20] C. Correll. Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead? , 2008, The Journal of clinical psychiatry.
[21] J. Cai,et al. Association of cardiac autonomic function and the development of hypertension: the ARIC study. , 1996, American journal of hypertension.
[22] Desmond E. Williams,et al. Prevalence and Correlates of Depressed Mood Among Youth With Diabetes: The SEARCH for Diabetes in Youth Study , 2006, Pediatrics.
[23] Francesca Bosetti,et al. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? , 2002, Archives of general psychiatry.
[24] Janet B W Williams,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[25] A. Douaihy,et al. A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report. , 2011, Journal of child and adolescent psychopharmacology.
[26] Ngianga-Bakwin Kandala,et al. Meta-analysis of short sleep duration and obesity in children and adults. , 2008, Sleep.
[27] J. Biederman,et al. Is bipolar disorder a risk for cigarette smoking in ADHD youth? , 2000, The American journal on addictions.
[28] A. Folsom,et al. Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk In Communities Study, 1987–1998 , 2003, Circulation.
[29] B. Goldstein. Recent progress in understanding pediatric bipolar disorder. , 2012, Archives of pediatrics & adolescent medicine.
[30] J. Fiedorowicz,et al. Mania and mortality: Why the excess cardiovascular risk in bipolar disorder? , 2009, Current psychiatry reports.
[31] Tara Gomes,et al. Risk of incident diabetes among patients treated with statins: population based study , 2013, BMJ.
[32] Richie Poulton,et al. Childhood maltreatment predicts adult inflammation in a life-course study , 2007, Proceedings of the National Academy of Sciences.
[33] Jagmeet P. Singh,et al. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. , 1998, Hypertension.
[34] J. Ballenger. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments , 2011 .
[35] M. Tsuang,et al. Causes of Death in Schizophrenia and Manic-Depression , 1980, British Journal of Psychiatry.
[36] J. O'Loughlin,et al. Depressive Symptoms and C-Reactive Protein Are Not Associated in a Population-Based Sample of Adolescents , 2010, International journal of behavioral medicine.
[37] G. Dibona. The sympathetic nervous system and hypertension: recent developments. , 2004, Hypertension.
[38] K. Matthews,et al. Sleep duration and insulin resistance in healthy black and white adolescents. , 2012, Sleep.
[39] P. Sienaert,et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. , 2013, The American journal of psychiatry.
[40] A. Danese,et al. Childhood maltreatment and obesity: systematic review and meta-analysis , 2014, Molecular Psychiatry.
[41] D. Simons-Morton,et al. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.
[42] B. Goldstein,et al. Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample. , 2009, The Journal of pediatrics.
[43] C. Mathers,et al. Global burden of disease in young people aged 10–24 years: a systematic analysis , 2011, The Lancet.
[44] K. Merikangas,et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.
[45] D. Jacobs,et al. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. , 2003, Diabetes care.
[46] K. Matthews,et al. Depressive symptoms and subclinical markers of cardiovascular disease in adolescents. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[47] Pasquale Strazzullo,et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. , 2011, European heart journal.
[48] A. Nierenberg,et al. Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2004, Biological Psychiatry.
[49] C. Fitzpatrick,et al. Depression in adolescence. , 1995, Irish medical journal.
[50] A. Merikangas,et al. The association between major depressive disorder and obesity in US adolescents: results from the 2001–2004 National Health and Nutrition Examination Survey , 2012, Journal of Behavioral Medicine.
[51] Masao Yoshizumi,et al. Endothelial function and oxidative stress in cardiovascular diseases. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[52] B. Penninx,et al. Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate Variability , 2010, Biological Psychiatry.
[53] G. Canino,et al. Psychiatric Disorders Associated with Substance Use Among Children and Adolescents: Findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study , 1997, Journal of abnormal child psychology.
[54] Manuel A. R. Ferreira,et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.
[55] I. Hickie,et al. Short sleep duration in prevalent and persistent psychological distress in young adults: the DRIVE study. , 2010, Sleep.
[56] C. Correll. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[57] C. Nemeroff,et al. Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.
[58] J. Viikari,et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[59] R. Salomon,et al. Increased oxidative stress in patients with depression and its relationship to treatment , 2013, Psychiatry Research.
[60] M. DelBello,et al. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. , 2009, Journal of child and adolescent psychopharmacology.
[61] Jitender Sareen,et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. , 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[62] P. Währborg,et al. Anger, depression and anxiety associated with endothelial function in childhood and adolescence , 2009, Archives of Disease in Childhood.
[63] S. Daniels,et al. Metabolic and Inflammatory Links to Depression in Youth With Diabetes , 2012, Diabetes Care.
[64] C. Levenson,et al. Role of zinc in the development and treatment of mood disorders , 2010, Current opinion in clinical nutrition and metabolic care.
[65] M. Vinberg,et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. , 2013, Journal of psychiatric research.
[66] I. Hickie,et al. Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression , 2013, BMC Medicine.
[67] N. Ryan,et al. Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. , 2008, The Journal of clinical psychiatry.
[68] R. Belmaker,et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. , 2006, The American journal of psychiatry.
[69] J. Vincent,et al. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder , 2012, Molecular Psychiatry.
[70] R. Shelton,et al. Oxidative stress and glutathione response in tissue cultures from persons with major depression. , 2012, Journal of psychiatric research.
[71] J Licinio,et al. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response , 2008, Molecular Psychiatry.
[72] Dante Cicchetti,et al. Child maltreatment. , 2005, Annual review of clinical psychology.
[73] R. McIntyre,et al. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. , 2008, Archives of pediatrics & adolescent medicine.
[74] R. Kessler,et al. Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. , 2012, Archives of general psychiatry.
[75] N. Ryan,et al. The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression. , 2013, Journal of child and adolescent psychopharmacology.
[76] K. Fletcher,et al. Screening for childhood trauma in adult primary care patients: a cross-sectional survey. , 2010, Primary care companion to the Journal of clinical psychiatry.
[77] David Finkelhor,et al. Violence, crime, and abuse exposure in a national sample of children and youth: an update. , 2013, JAMA pediatrics.
[78] K. Matthews,et al. Childhood physical abuse is associated with incident metabolic syndrome in mid-life women. , 2013, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[79] G. Parker,et al. ‘D’ for depression: any role for vitamin D? , 2011, Acta psychiatrica Scandinavica.
[80] Rongwei Fu,et al. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[81] H. Bogner,et al. Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial , 2012, The Annals of Family Medicine.
[82] James A. Blumenthal,et al. Depression, Heart Rate Variability, and Acute Myocardial Infarction , 2001, Circulation.
[83] R. McIntyre,et al. The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. , 2012, The Primary Care Companion For CNS Disorders.
[84] R. Mojtabai. Antidepressant use and glycemic control , 2013, Psychopharmacology.
[85] Do Peterson,et al. Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.
[86] L. Smeeth,et al. The association between antipsychotic agents and the risk of myocardial infarction: a systematic review , 2011, British journal of clinical pharmacology.
[87] Ganesh Dakhale,et al. Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.
[88] R. McIntyre,et al. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent‐onset bipolar disorder , 2011, Human psychopharmacology.
[89] Shih-Yi Huang,et al. A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression , 2010, Biological Psychiatry.
[90] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[91] K. Markides,et al. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. , 2003, Diabetes care.
[92] C. Nemeroff,et al. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.
[93] C. Nemeroff,et al. The link between childhood trauma and depression: Insights from HPA axis studies in humans , 2008, Psychoneuroendocrinology.
[94] D. Ramsdale,et al. Smoking and coronary artery disease assessed by routine coronary arteriography. , 1985, British medical journal.
[95] R. Clouse,et al. Recent advances in understanding depression in adults with diabetes , 2007, Current diabetes reports.
[96] M. Irwin. Psychoneuroimmunology of Depression: Clinical Implications , 2002, Brain, Behavior, and Immunity.
[97] R. Armitage,et al. Sex and age differences in sleep macroarchitecture in childhood and adolescent depression. , 2006, Sleep.
[98] David Brent,et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[99] J. Biederman,et al. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial , 2007, European Neuropsychopharmacology.
[100] R. McIntyre,et al. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. , 2010, The Journal of clinical psychiatry.
[101] N. Wray,et al. Research review: the role of cytokines in depression in adolescents: a systematic review. , 2013, Journal of child psychology and psychiatry, and allied disciplines.
[102] D. Chapman,et al. Insights Into Causal Pathways for Ischemic Heart Disease: Adverse Childhood Experiences Study , 2004, Circulation.
[103] Satoshi Sasaki,et al. Fish and n-3 Polyunsaturated Fatty Acid Intake and Depressive Symptoms: Ryukyus Child Health Study , 2010, Pediatrics.
[104] Duanping Liao,et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. , 2002, Diabetes.
[105] A. Harvey,et al. Sleep and circadian rhythms in children and adolescents with bipolar disorder , 2006, Development and Psychopathology.
[106] K. Kendler,et al. Toward a Comprehensive Developmental Model for Major Depression in Women , 2002 .
[107] G. Miller,et al. Multiwave Associations Between Depressive Symptoms and Endothelial Function in Adolescent and Young Adult Females , 2011, Psychosomatic medicine.
[108] Rita A. Longaker,et al. Exercise tolerance is reduced in bipolar illness. , 2007, Journal of affective disorders.
[109] J. Ballenger. A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and Adolescents , 2013 .
[110] R. McIntyre,et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. , 2009, The Journal of clinical psychiatry.
[111] P. Jensen,et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, Assessment, and Initial Management , 2007, Pediatrics.
[112] Peter J. Schwartz,et al. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias Implications for Clinical Trials , 2001 .
[113] M. Carter. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. , 2014 .
[114] S. Daniels,et al. Use of the metabolic syndrome in pediatrics: a blessing and a curse. , 2009, Seminars in pediatric surgery.
[115] L. Alfredsson,et al. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden , 2013, BMJ Open.
[116] M. Dubé,et al. Genetic predictors of depressive symptoms in cardiac patients , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[117] P. López-Jaramillo,et al. Plasma Nitrate Levels and Flow-Mediated Vasodilation in Untreated Major Depression , 2011, Psychosomatic medicine.
[118] S. Szanton,et al. Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies , 2014, Psychosomatic medicine.
[119] M. Berk,et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[120] J. Markowitz,et al. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. , 1999, Journal of affective disorders.
[121] M. Fava,et al. Preadult onset vs. adult onset of major depressive disorder: a replication study , 2007, Acta psychiatrica Scandinavica.
[122] R. McIntyre,et al. Bipolar disorder and metabolic syndrome: an international perspective. , 2010, Journal of affective disorders.
[123] Martin P Paulus,et al. Heart rate variability in bipolar mania and schizophrenia. , 2010, Journal of psychiatric research.
[124] M. DelBello,et al. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. , 2010, Bipolar disorders.
[125] D. Levy,et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. , 1996, Circulation.
[126] D. Clark,et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. , 2004, Addictive behaviors.
[127] Chris Parker,et al. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. , 2007, Archives of general psychiatry.
[128] Barbara Napolitano,et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. , 2009, JAMA.
[129] N. Allen,et al. Autonomic cardiac control in depressed adolescents , 2010, Depression and anxiety.
[130] G. Högberg,et al. Depressed adolescents in a case‐series were low in vitamin D and depression was ameliorated by vitamin D supplementation , 2012, Acta paediatrica.
[131] B. Goldstein,et al. Pharmacologic treatment of bipolar disorder in children and adolescents. , 2012, Child and adolescent psychiatric clinics of North America.
[132] D. F. Drake,et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.
[133] I. Ferrier,et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. , 2009, Bipolar disorders.
[134] F. Zitman,et al. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). , 2008, Archives of general psychiatry.
[135] C. Blanco,et al. The burden of obesity among adults with bipolar disorder in the United States , 2011, Bipolar disorders.
[136] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[137] J. Rice,et al. Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder , 2009, Psychosomatic medicine.
[138] N. Ryan,et al. Significance of cigarette smoking among youths with bipolar disorder. , 2008, The American journal on addictions.
[139] Mark Olfson,et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.
[140] J. Viikari,et al. Depressive Symptoms and Carotid Artery Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2005, Psychosomatic medicine.
[141] S Woolhandler,et al. Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.
[142] C. Lyketsos,et al. Examining a bidirectional association between depressive symptoms and diabetes. , 2008, JAMA.
[143] C. Enger,et al. Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia , 2013, International journal of adolescent medicine and health.
[144] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[145] S. Selek,et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[146] T. Suppes,et al. The poor prognosis of childhood-onset bipolar disorder. , 2007, The Journal of pediatrics.
[147] M. Alda,et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. , 1995, Journal of affective disorders.
[148] M. Hori,et al. PE-050 Neointimal Hyperplasia was Greater between 3 and 8 Months Follow-up after Sirolimus-eluting Stent Implantation in Small Vessels with Calcified Lesions(PE009,Coronary Revascularization, PCI (DES) 2 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation So , 2009 .
[149] J. Gorman,et al. Heart rate variability in depressive and anxiety disorders. , 2000, American heart journal.
[150] Yogesh K. Dwivedi,et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. , 2010, Journal of affective disorders.
[151] Roberto Elosua,et al. A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction. , 2011, Cardiovascular research.
[152] B. Birmaher,et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. , 2011, Journal of child and adolescent psychopharmacology.
[153] U. P. S. T. Force. Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement , 2009, Pediatrics.
[154] R. Carney,et al. The Association Between Major Depressive Disorder in Childhood and Risk Factors for Cardiovascular Disease in Adolescence , 2014, Psychosomatic medicine.
[155] P. Gean,et al. The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients. , 2013, Journal of affective disorders.
[156] A. Harvey,et al. The complex role of sleep in adolescent depression. , 2012, Child and adolescent psychiatric clinics of North America.
[157] R. Rugulies. Depression as a predictor for coronary heart disease. a review and meta-analysis. , 2002, American journal of preventive medicine.
[158] O. Almeida,et al. Depression and smoking amongst older general practice patients. , 2005, Journal of affective disorders.
[159] H. Sies. Oxidative stress: from basic research to clinical application. , 1991, The American journal of medicine.
[160] Amit J. Shah,et al. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. , 2011, Archives of general psychiatry.
[161] M. Vinberg,et al. Cytokines in bipolar disorder: a systematic review and meta-analysis. , 2013, Journal of affective disorders.
[162] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[163] Rosalind J Wright,et al. Physical and Sexual Abuse in Childhood as Predictors of Early-Onset Cardiovascular Events in Women , 2012, Circulation.
[164] M. Höfler,et al. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults , 2007, Psychological Medicine.
[165] X. Zhang,et al. The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia , 2003, Journal of clinical psychopharmacology.
[166] A. Quyyumi,et al. Major depression and coronary flow reserve detected by positron emission tomography. , 2009, Archives of internal medicine.
[167] Viola Vaccarino,et al. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association , 2014, Circulation.
[168] K. Felmingham,et al. Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis , 2010, Biological Psychiatry.
[169] Michelle Shardell,et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. , 2010, The Journal of clinical endocrinology and metabolism.
[170] K. Su,et al. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.
[171] Jeannie-Marie S. Leoutsakos,et al. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study. , 2010, Journal of affective disorders.
[172] O. Shirihai,et al. Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus , 2011, Circulation.
[173] A. Reiff,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 2000, The New England journal of medicine.
[174] P. Jensen,et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management , 2007, Pediatrics.
[175] Nathan Clark. Consensus development conference on antipsychotic drugs and obesity and diabetes. , 2004, The Journal of clinical psychiatry.
[176] Benicio N Frey,et al. Oxidative stress markers in bipolar disorder: a meta-analysis. , 2008, Journal of affective disorders.
[177] S. Kennedy,et al. The Association between Childhood Adversity and Components of Metabolic Syndrome in Adults with Mood Disorders: Results from the International Mood Disorders Collaborative Project , 2012, International journal of psychiatry in medicine.
[178] C. Gottfried,et al. Serum S100B and antioxidant enzymes in bipolar patients. , 2007, Journal of psychiatric research.
[179] D. Martínez-Gómez,et al. Sedentarismo, adiposidad y factores de riesgo cardiovascular en adolescentes. Estudio AFINOS , 2010 .
[180] J. Thayer,et al. Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults. , 2013, International journal of cardiology.
[181] K. Swedberg. n-3 Fatty acids in cardiovascular disease. , 2011, The New England journal of medicine.
[182] S. Rapoport,et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients , 2010, Molecular Psychiatry.
[183] S. Stewart,et al. Depressive symptoms and smoking among Hong Kong Chinese adolescents. , 2005, Addiction.
[184] R. McIntyre,et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. , 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[185] R. Carney,et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. , 2009, JAMA.
[186] G. Bernal,et al. State of the science on psychosocial interventions for ethnic minorities. , 2005, Annual review of clinical psychology.
[187] M. Garg,et al. Long-Chain Omega-3 Polyunsaturated Fatty Acids in the Blood of Children and Adolescents with Juvenile Bipolar Disorder , 2008, Lipids.
[188] D. Clark,et al. Gender and comorbid psychopathology in adolescents with alcohol dependence. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[189] V. Helgeson,et al. Children with Diabetes Compared to Peers: Depressed? Distressed? , 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[190] P. Kris-Etherton,et al. The role of diet and nutritional supplements in preventing and treating cardiovascular disease , 2009, Current opinion in cardiology.
[191] G. Faulkner,et al. Bipolar disorder and leisure-time physical activity: Results from a national survey of Canadians , 2009 .
[192] R. Callaghan,et al. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada. , 2010, Journal of affective disorders.
[193] S. Rapoport,et al. Chronic Administration of Lamotrigine Downregulates COX-2 mRNA and Protein in Rat Frontal Cortex , 2008, Neurochemical Research.
[194] A. Mykletun,et al. Diet quality in bipolar disorder in a population-based sample of women. , 2011, Journal of affective disorders.
[195] R. McIntyre,et al. Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap , 2009, Current diabetes reports.
[196] N. Herrmann,et al. A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.
[197] K. Juel,et al. Cardiovascular death and manic-depressive psychosis. , 1987, Journal of affective disorders.
[198] S. Gabriel,et al. Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.
[199] J. Jerrell,et al. Neurological and Cardiovascular Adverse Events Associated with Antimanic Treatment in Children and Adolescents , 2010, CNS neuroscience & therapeutics.
[200] P. Ridker. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. , 2007, Nutrition reviews.
[201] A Voss,et al. Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. , 2006, Bipolar disorders.
[202] W. Nolen,et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.
[203] U. Förstermann,et al. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. , 2008, Clinical chemistry.
[204] W. Sadee,et al. CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response , 2009, Circulation. Cardiovascular genetics.
[205] R. Kessler,et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. , 2010, Archives of general psychiatry.
[206] J. Rabe-Jabłońska,et al. [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.
[207] A. Kilbourne,et al. Nutrition and exercise behavior among patients with bipolar disorder. , 2007, Bipolar disorders.
[208] A. Harvey. The adverse consequences of sleep disturbance in pediatric bipolar disorder: implications for intervention. , 2009, Child and adolescent psychiatric clinics of North America.
[209] S. Cole,et al. Clustering of Depression and Inflammation in Adolescents Previously Exposed to Childhood Adversity , 2012, Biological Psychiatry.
[210] J. Racoosin,et al. Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. , 2004, Diabetes care.
[211] Andrea L Dunn,et al. Inverse association between physical inactivity and mental health in men and women. , 2006, Medicine and science in sports and exercise.
[212] M. Rubenfire,et al. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.
[213] Suzanne G. Leveille,et al. Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. , 1999, American journal of public health.
[214] Daniel M. Hartung,et al. Metabolic screening in children receiving antipsychotic drug treatment. , 2010, Archives of pediatrics & adolescent medicine.
[215] J. McClellan,et al. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[216] A L Dannenberg,et al. Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. , 1988, American journal of epidemiology.
[217] K. Brady,et al. Cigarette smoking and psychiatric comorbidity in children and adolescents. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[218] J. Hibbeln,et al. Cross-national comparisons of seafood consumption and rates of bipolar disorders. , 2003, The American journal of psychiatry.
[219] M. Ingvar,et al. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. , 2012, Journal of affective disorders.
[220] B. Goldstein,et al. Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the national epidemiologic survey on alcohol and related conditions. , 2006, The American journal of psychiatry.
[221] B. Bondy,et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. , 2011, The Journal of clinical psychiatry.
[222] Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. , 2002, American journal of epidemiology.
[223] E. Brietzke,et al. Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies , 2013, Biological Psychiatry.
[224] E. Costello,et al. Cumulative Depression Episodes Predict Later C-Reactive Protein Levels: A Prospective Analysis , 2012, Biological Psychiatry.
[225] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[226] J Thomas Bigger,et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.
[227] V. Parikh,et al. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[228] M. Kandefer-Szerszeń,et al. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[229] David J Kupfer,et al. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. , 2009, Bipolar disorders.
[230] Mark E Molitch,et al. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.
[231] J. Babb,et al. Immune system dysregulation in adolescent major depressive disorder. , 2009, Journal of affective disorders.
[232] M. Weissman,et al. The association between childhood depression and adulthood body mass index. , 2001, Pediatrics.
[233] P. Sparén,et al. Excess mortality in bipolar and unipolar disorder in Sweden. , 2001, Archives of general psychiatry.
[234] B. Druss,et al. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. , 2010, The American journal of psychiatry.
[235] J. Eisenmann,et al. Sedentary behavior, adiposity and cardiovascular risk factors in adolescents. The AFINOS study. , 2010, Revista espanola de cardiologia.
[236] M. Barclay,et al. Manic-Depressive Insanity and Paranoia , 1921, The Indian Medical Gazette.
[237] B. Birmaher,et al. Treatment guidelines for children and adolescents with bipolar disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[238] Kenneth S Kendler,et al. Toward a comprehensive developmental model for major depression in men. , 2006, The American journal of psychiatry.
[239] A. Must,et al. Adolescent Obesity and Risk for Subsequent Major Depressive Disorder and Anxiety Disorder: Prospective Evidence , 2007, Psychosomatic medicine.
[240] O. Bukstein,et al. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. , 2010, The Journal of clinical psychiatry.
[241] D. Mischoulon,et al. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. , 2012, The Journal of clinical psychiatry.
[242] H. Critchley,et al. Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity , 2009, Biological Psychiatry.
[243] N. Herrmann,et al. Zinc in Depression: A Meta-Analysis , 2013, Biological Psychiatry.
[244] K. Chayama,et al. Endothelial function and oxidative stress in renovascular hypertension. , 2002, The New England journal of medicine.
[245] Cinnamon A. Stetler,et al. A Meta-Analytic Review of the Effects of Childhood Abuse on Medical Outcomes in Adulthood , 2009, Psychosomatic medicine.
[246] Jeffrey S. Gonzalez,et al. A review of treating depression in diabetes: emerging findings. , 2011, Psychosomatics.
[247] D. Todder,et al. Nonlinear analysis of RR interval in euthymic bipolar disorder , 2005, Autonomic Neuroscience.
[248] V. Meyer-Rochow,et al. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort , 2006, Molecular Psychiatry.
[249] D. Cicchetti,et al. Diverse patterns of neuroendocrine activity in maltreated children , 2001, Development and Psychopathology.
[250] A. Lichtenstein. Nutrient supplements and cardiovascular disease: a heartbreaking story Published, JLR Papers in Press, November 6, 2008. , 2009, Journal of Lipid Research.
[251] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[252] D. James,et al. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. , 2009, Bipolar disorders.
[253] A K Manatunga,et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.
[254] North American Association for the Study of Obesity , 1991, International journal of obesity.
[255] J. Fiedorowicz,et al. Vascular function is not impaired early in the course of bipolar disorder. , 2012, Journal of psychosomatic research.
[256] G. Kenis,et al. Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.
[257] A. Caspi,et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. , 2009, Archives of pediatrics & adolescent medicine.
[258] A. Danese,et al. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. , 2011, The American journal of psychiatry.
[259] Charles L. Raison,et al. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.
[260] W. Brown,et al. Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. , 2013, JAMA psychiatry.
[261] A. Kilbourne,et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. , 2008, Psychiatric services.
[262] D. Axelson,et al. Early intervention for adolescents at high risk for the development of bipolar disorder: pilot study of Interpersonal and Social Rhythm Therapy (IPSRT). , 2014, Psychotherapy.
[263] S. Sasaki,et al. Dietary intake and depressive symptoms: a systematic review of observational studies. , 2010, Molecular nutrition & food research.
[264] F. Dickerson,et al. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[265] A J Camm,et al. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.
[266] T. Su,et al. Comorbidity of cardiovascular diseases with mood and anxiety disorder: A population based 4‐year study , 2009, Psychiatry and clinical neurosciences.
[267] S. Strakowski,et al. Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics. , 2007, Journal of child and adolescent psychopharmacology.
[268] J. Biederman,et al. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[269] S. Patten,et al. Lifestyle Characteristics of Psychiatric Outpatients , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[270] Rebecca Tillman,et al. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. , 2008, Archives of general psychiatry.
[271] B. Vitiello,et al. Pharmacotherapy of bipolar disorder in children and adolescents , 2006 .
[272] R. Kessler,et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. , 1996, Archives of general psychiatry.
[273] G. Miller,et al. Where There Is Depression, There Is Inflammation․․․Sometimes! , 2007, Biological Psychiatry.
[274] C. Correll. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. , 2008, The Journal of clinical psychiatry.
[275] K. Torén,et al. Cardiovascular fitness in males at age 18 and risk of serious depression in adulthood: Swedish prospective population-based study. , 2012, The British journal of psychiatry : the journal of mental science.
[276] J. Newcomer,et al. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. , 2009, The American journal of psychiatry.
[277] P. Cowen,et al. Cardiovascular and metabolic risk profile in young people at familial risk of depression , 2013, British Journal of Psychiatry.